Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A27647 | 17766001 | Diabetes Res Clin Pract | Effect of a hypocaloric diet in transaminases in nonalcoholic fatty liver disease and obese patients, relation with insulin resistance. | 2007 | Details |
A27648 | 17764776 | Diabetes Res Clin Pract | Probable NAFLD, by ALT levels, and diabetes among Filipino-American women. | 2007 | Details |
A27649 | 17764530 | J Gastroenterol Hepatol | Reduction of fibrosis in a rat model of non-alcoholic steatohepatitis cirrhosis by human HGF gene transfection using electroporation. | 2007 | Details |
A27650 | 17761893 | J Endocrinol | Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet. | 2007 | Details |
A27651 | 19669329 | Hepatol Int | Current and novel therapies for the treatment of nonalcoholic steatohepatitis. | 2007 | Details |
A27652 | 17729403 | World J Gastroenterol | Pathogenesis and management issues for non-alcoholic fatty liver disease. | 2007 | Details |
A27653 | 17728149 | Ann Epidemiol | Nonalcoholic fatty liver disease. | 2007 | Details |
A27654 | 17725609 | Intern Med J | Endothelial dysfunction in Turkish patients with non-alcoholic fatty liver disease. | 2007 | Details |
A27655 | 17724809 | World J Gastroenterol | Association of the frequency of peripheral natural killer T cells with nonalcoholic fatty liver disease. | 2007 | Details |
A27656 | 17722791 | Tunis Med | [Role of mitochondrial dysfunction in non-alcoholic steatohepatitis]. | 2003 | Details |
A27657 | 17716660 | FEBS Lett | Role of ChREBP in hepatic steatosis and insulin resistance. | 2007 | Details |
A27658 | 17716352 | J Gastroenterol Hepatol | Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan. | 2007 | Details |
A27659 | 17567478 | J Gastroenterol Hepatol | Non-alcoholic steatohepatitis and hepatocellular carcinoma: lessons from hepatocyte-specific phosphatase and tensin homolog (PTEN)-deficient mice. | 2007 | Details |
A27660 | 17567476 | J Gastroenterol Hepatol | Role of adipocytokines in hepatic fibrogenesis. | 2007 | Details |
A27661 | 17567475 | J Gastroenterol Hepatol | Role of oxidative stress and Kupffer cells in hepatic fibrosis. | 2007 | Details |
A27662 | 17567459 | J Gastroenterol Hepatol | Role of mitochondria in non-alcoholic fatty liver disease. | 2007 | Details |
A27663 | 17567458 | J Gastroenterol Hepatol | Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)? | 2007 | Details |
A27664 | 17715267 | Gut | Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years. | 2007 | Details |
A27665 | 17711101 | Rocz Panstw Zakl Hig | Nonalcoholic fatty liver disease as a feature of the metabolic syndrome. | 2007 | Details |
A27667 | 17709876 | Cell Biochem Biophys | Childhood obesity and insulin resistance. | 2007 | Details |
A27668 | 17708600 | World J Gastroenterol | Female hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection. | 2007 | Details |
A27669 | 17708287 | Hepatogastroenterology | Factors affecting the serum levels of adipokines in Korean male patients with nonalcoholic fatty liver disease. | 2007 | Details |
A27670 | 17706260 | Toxicol Appl Pharmacol | Gene expression profiling reveals underlying molecular mechanisms of the early stages of tamoxifen-induced rat hepatocarcinogenesis. | 2007 | Details |
A27671 | 17702954 | Am J Physiol Gastrointest Liver Physiol | Involvement of AMP-activated protein kinase in beneficial effects of betaine on high-sucrose diet-induced hepatic steatosis. | 2007 | Details |
A27672 | 17702661 | Clin Gastroenterol Hepatol | Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass. | 2007 | Details |
A27673 | 17700213 | Coron Artery Dis | Association between nonalcoholic fatty liver disease and coronary artery disease. | 2007 | Details |
A27674 | 17696255 | World J Gastroenterol | Common genetic variations in CLOCK transcription factor are associated with nonalcoholic fatty liver disease. | 2007 | Details |
A27675 | 17694770 | Niger J Med | Diabetes co-existing with chronic liver disease: clinical features and response to therapy. | 2007 | Details |
A27676 | 17691915 | Curr Drug Discov Technol | Current treatment strategies for non-alcoholic fatty liver disease (NAFLD). | 2007 | Details |
A27677 | 17690317 | Arterioscler Thromb Vasc Biol | Fatty liver: a novel component of the metabolic syndrome. | 2007 | Details |
A27678 | 17684626 | Arq Bras Endocrinol Metabol | [Non-alcoholic steatohepatitis induced by fast weight loss during the use of intragastric balloon--a case report]. | 2007 | Details |
A27679 | 17684197 | Am J Clin Nutr | Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. | 2007 | Details |
A27680 | 17683497 | J Gastroenterol Hepatol | Epigallocatechin gallate attenuates experimental non-alcoholic steatohepatitis induced by high fat diet. | 2007 | Details |
A27681 | 17683488 | J Gastroenterol Hepatol | Protein glutathionylation increases in the liver of patients with non-alcoholic fatty liver disease. | 2007 | Details |
A27682 | 17682977 | Semin Liver Dis | Definitive diagnosis and assessment of risk for nonalcoholic fatty liver disease in children and adolescents. | 2007 | Details |
A27683 | 17675901 | J Cardiometab Syndr | Nonalcoholic steatohepatitis and the cardiometabolic syndrome. | 2006 | Details |
A27684 | 17671740 | Int J Mol Med | Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. | 2007 | Details |
A27686 | 17669243 | Zhonghua Gan Zang Bing Za Zhi | [The relationship between insulin resistance and adiponectin gene expression in nonalcoholic fatty liver disease]. | 2007 | Details |
A27687 | 17667992 | Nat Clin Pract Gastroenterol Hepatol | Evaluation and management of obesity-related nonalcoholic fatty liver disease. | 2007 | Details |
A27688 | 17661414 | Hepatology | Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. | 2007 | Details |
A27689 | 17659713 | World J Gastroenterol | Visceral fat and insulin resistance as predictors of non-alcoholic steatohepatitis. | 2007 | Details |
A27690 | 17659704 | World J Gastroenterol | Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease. | 2007 | Details |
A27691 | 17657385 | Singapore Med J | Significant non-alcoholic fatty liver disease is found in non-diabetic, pre-obese Chinese in Singapore. | 2007 | Details |
A27693 | 17655622 | Acta Paediatr | Nonalcoholic fatty liver disease in overweight children and adolescents. | 2007 | Details |
A27694 | 17654743 | Hepatology | A lipidomic analysis of nonalcoholic fatty liver disease. | 2007 | Details |
A27695 | 17654601 | Hepatology | Effects of rosiglitazone on the liver histology and mitochondrial function in ob/ob mice. | 2007 | Details |
A27696 | 17654578 | Magn Reson Med | Fat quantification with IDEAL gradient echo imaging: correction of bias from T(1) and noise. | 2007 | Details |
A27697 | 17653654 | J Gastroenterol | High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH. | 2007 | Details |
A27698 | 17646074 | Eur J Radiol | Separation of advanced from mild fibrosis in diffuse liver disease using 31P magnetic resonance spectroscopy. | 2007 | Details |
A27699 | 17640958 | Drug Metab Dispos | Efflux transporter expression and acetaminophen metabolite excretion are altered in rodent models of nonalcoholic fatty liver disease. | 2007 | Details |
A27700 | 17628189 | Vitam Horm | Vitamin E in chronic liver diseases and liver fibrosis. | 2007 | Details |
A27701 | 17627552 | Curr Pharm Des | Non-alcoholic fatty liver disease in the metabolic syndrome. | 2007 | Details |
A27702 | 17619535 | Acta Gastroenterol Belg | Pathogenesis of steatohepatitis: insights from the study of animal models. | 2007 | Details |
A27703 | 17618414 | Diabetologia | Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice. | 2007 | Details |
A27704 | 17610277 | Hepatology | The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome. | 2007 | Details |
A27705 | 17608855 | J Gastroenterol Hepatol | Effects of nonalcoholic fatty liver disease on the development of metabolic disorders. | 2007 | Details |
A27706 | 17608262 | Obes Surg | IL-6 and IGF-1 are independent prognostic factors of liver steatosis and non-alcoholic steatohepatitis in morbidly obese patients. | 2007 | Details |
A27707 | 17608261 | Obes Surg | Resolution of nonalcoholic steatohepatits after gastric bypass surgery. | 2007 | Details |
A27708 | 17605315 | Nutr Rev | Obesity and nonalcoholic fatty liver disease. | 2007 | Details |
A27709 | 17603886 | J Autoimmune Dis | The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders. | 2007 | Details |
A27710 | 17596883 | Hepatology | A comparison of associations of alanine aminotransferase and gamma-glutamyltransferase with fasting glucose, fasting insulin, and glycated hemoglobin in women with and without diabetes. | 2007 | Details |
A27711 | 17596878 | Hepatology | A systems biology approach to the pathogenesis of obesity-related nonalcoholic fatty liver disease using reverse phase protein microarrays for multiplexed cell signaling analysis. | 2007 | Details |
A27712 | 17593595 | Medicina (B Aires) | Alanine-aminotransferase: an early marker for insulin resistance? | 2007 | Details |
A27713 | 17589946 | World J Gastroenterol | Frequency of primary iron overload and HFE gene mutations (C282Y, H63D and S65C) in chronic liver disease patients in north India. | 2007 | Details |
A27714 | 17585191 | Korean J Hepatol | [The prevalence of peripheral iron overload and the presence of HFE gene (H63D) mutation among the Korean patients with nonalcoholic fatty liver disease]. | 2007 | Details |
A27715 | 17566116 | Am J Physiol Endocrinol Metab | Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice. | 2007 | Details |
A27716 | 17565632 | J Gastroenterol Hepatol | How should we manage patients with non-alcoholic fatty liver disease in 2007? | 2007 | Details |
A27717 | 17565631 | J Gastroenterol Hepatol | How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? | 2007 | Details |
A27718 | 17565630 | J Gastroenterol Hepatol | Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines. | 2007 | Details |
A27721 | 17563923 | Cell Biochem Funct | Methylenetetrahydrofolate reductase gene polymorphisms in patients with nonalcoholic steatohepatitis (NASH). | 2008 | Details |
A27722 | 17560682 | J Hepatol | Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. | 2007 | Details |
A27723 | 17560678 | J Hepatol | Pioglitazone treatment increases whole body fat but not total body water in patients with non-alcoholic steatohepatitis. | 2007 | Details |
A27724 | 17560098 | Nutr Metab Cardiovasc Dis | Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question. | 2007 | Details |
A27725 | 17559420 | Hepatol Res | Decrease in accumulation of ultrasound contrast microbubbles in non-alcoholic steatohepatitis. | 2007 | Details |
A27726 | 17558337 | J Acquir Immune Defic Syndr | HIV-positive patients with nonalcoholic fatty liver disease have a lower body mass index and are more physically active than HIV-negative patients. | 2007 | Details |
A27727 | 17555424 | Aliment Pharmacol Ther | Long-term follow-up of patients with mild to moderate drug-induced liver injury. | 2007 | Details |
A27728 | 17552019 | World J Gastroenterol | Therapeutic strategies for pediatric non-alcoholic fatty liver disease: a challenge for health care providers. | 2007 | Details |
A27729 | 17547835 | Curr Diab Rep | Nonalcoholic fatty liver disease and cardiovascular disease risk. | 2007 | Details |
A27730 | 17544980 | Clin Liver Dis | The role of genomics and proteomics: technologies in studying non-alcoholic fatty liver disease. | 2007 | Details |
A27731 | 17544979 | Clin Liver Dis | Non-alcoholic steatohepatitis and cancer. | 2007 | Details |
A27732 | 17544977 | Clin Liver Dis | Non-alcoholic steatohepatitis in children. | 2007 | Details |
A27733 | 17544976 | Clin Liver Dis | Surgical treatment for obesity and its impact on non-alcoholic steatohepatitis. | 2007 | Details |
A27734 | 17544974 | Clin Liver Dis | Metabolic syndrome and NASH. | 2007 | Details |
A27735 | 17544973 | Clin Liver Dis | Pathogenesis of non-alcoholic steatohepatitis: human data. | 2007 | Details |
A27736 | 17544972 | Clin Liver Dis | Pathogenesis of NASH: animal models. | 2007 | Details |
A27737 | 17544971 | Clin Liver Dis | Role of radiologic modalities in the management of non-alcoholic steatohepatitis. | 2007 | Details |
A27738 | 17544970 | Clin Liver Dis | Role of liver biopsy and serum markers of liver fibrosis in non-alcoholic fatty liver disease. | 2007 | Details |
A27739 | 17544969 | Clin Liver Dis | Pathologic assessment of non-alcoholic fatty liver disease. | 2007 | Details |
A27740 | 17544968 | Clin Liver Dis | Epidemiology and natural history of NAFLD and NASH. | 2007 | Details |
A27741 | 17542290 | Trop Gastroenterol | Nonalcoholic fatty liver disease in India--is it different? | 2007 | Details |
A27743 | 17542283 | Rev Gastroenterol Mex | [Therapeuric aspects of NAFLD. A literature review]. | 2007 | Details |
A27744 | 17542278 | Rev Gastroenterol Mex | [Prevalence of NAFLD and metabolic syndrome in asymtomatics subjects]. | 2007 | Details |
A27745 | 17542277 | Rev Gastroenterol Mex | [Frequency of NAFLD in a group of patients with metabolic syndrome in Veracruz, Mexico]. | 2007 | Details |
A27746 | 17539815 | Hepatol Res | A prospective study of acute drug-induced liver injury in patients suffering from non-alcoholic fatty liver disease. | 2007 | Details |
A27747 | 19669352 | Hepatol Int | Role of growth hormone, insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 in development of non-alcoholic fatty liver disease. | 2007 | Details |
A27748 | 17531973 | Exp Cell Res | From Mallory to Mallory-Denk bodies: what, how and why? | 2007 | Details |
A27749 | 17526931 | J Biol Chem | Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance. | 2007 | Details |
A27750 | 17524368 | Biochem Pharmacol | Modulation of hepatic microsomal triglyceride transfer protein (MTP) induced by S-nitroso-N-acetylcysteine in ob/ob mice. | 2007 | Details |
A27751 | 17520517 | Semin Liver Dis | The role of cytokines and chemokines in the development of steatohepatitis. | 2007 | Details |
A27752 | 17519831 | Ann Hepatol | What is the reason of elevated alanine aminotransferase level in HBeAg negative patients with low viremia: NAFLD or chronic hepatitis? | 2007 | Details |